Tag:
Latest Headlines
Latest Headlines
Join a live Twitter chat with Medidata's Glen de Vries
De Vries and I have spoken several times over the past year about how cloud computing and other innovations are changing the way clinical trials data and operations are managed. We recently agreed to host one such chat in the Twitterverse.
Roche helps corral diabetes chitchat from Twitter
The Swiss drug giant is zeroing in on the diabetes community with the recent launch of a page on the social networking site called Diabetes Nest.
Tech startup cuts through social media noise for drug and device outfits
LiquidGrids's tech crawls the vast social media universe and picks up health-related conversations; the company hopes to find clients that will pay to hear what's being said.
Consumers to pharma: Let's be Facebook friends (or not)
Drugmakers often get a bad rap among consumers for questionable marketing practices and events like the Vioxx scandal. Yet a consumer survey shows that, at least in online circles, pharma isn't as
FDA: No off-label sharing in social media
As 2011 drew to a close, the FDA made a move destined to cause complaint: It issued a draft guidance for pharma communications online, via social media and otherwise. The guidance came more than a
FDA dishes out long-awaited guidance on social media
With drug and device makers seeking rules of the social media road from regulators, the FDA quietly issued draft guidance to shed light on its thinking about a specific area of concern for pharma
Pfizer takes lead in race for social media clout
Drugmakers all over the world are boosting their campaigns on social platforms such as Facebook and Twitter, building followings in hopes of advancing certain business objectives. A new study shows
Study ranks Pfizer, Roche, peers on Facebook, Twitter
As drugmakers look to gain greater influence on social media platforms, some companies have obviously been more successful than others. A new study has ranked the social networking statuses of major
Want Europeans' attention? Use websites, not Twitter, study finds
Is social media really the bright new frontier for pharma communications? Or are consumers less interested in pharma on Facebook and Twitter than pharma marketing types would like them to be? A new
Twitter opinions linked to vaccine uptake
Penn State University researchers have developed an algorithm capable of analyzing the tone of updates on the microblogging site Twitter to determine users' opinions of vaccines. The researchers were
